Viral load and disease severity in COVID-19

被引:15
|
作者
Pawar, Rahul Dnyaneshwar [1 ,2 ]
Balaji, Lakshman [2 ]
Mehta, Shivani [2 ]
Cole, Andrew [2 ]
Liu, Xiaowen [2 ]
Peradze, Natia [2 ]
Grossestreuer, Anne Victoria [2 ]
Issa, Mahmoud Salah [2 ]
Patel, Parth [2 ]
Kirby, James Edward [4 ]
Rowley, Christopher Francis [5 ]
Berg, Katherine Margaret [2 ,3 ]
Moskowitz, Ari [2 ,3 ]
Donnino, Michael William [2 ,3 ]
机构
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Hosp Med, 1 Deaconess Rd, Boston, MA 02215 USA
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Resuscitat Sci, Dept Emergency Med, Boston, MA 02115 USA
[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02115 USA
[4] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA
[5] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Infect Dis, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
COVID-19; Coronavirus; SARS-CoV-2; Viral load; RT-PCR; Organ dysfunction score; INFLUENZA; INFECTION; SEPSIS;
D O I
10.1007/s11739-021-02786-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between COVID-19 severity and viral load is unknown. Our objective was to assess the association between viral load and disease severity in COVID-19. In this single center observational study of adults with laboratory confirmed SARS-CoV-2, the first positive in-hospital nasopharyngeal swab was used to calculate the log10 copies/ml [log10 copy number (CN)] of SARS-CoV-2. Four categories based on level of care and modified sequential organ failure assessment score (mSOFA) at time of swab were determined. Median log10CN was compared between different levels of care and mSOFA quartiles. Median log10CN was compared in patients who did and did not receive influenza vaccine, and the correlation between log10CN and D-dimer was examined. We found that of 396 patients, 54.3% were male, and 25% had no major comorbidity. Hospital mortality was 15.7%. Median mSOFA was 2 (IQR 0-3). Median log10CN was 5.5 (IQR 3.3-8.0). Median log10CN was highest in non-intubated ICU patients [6.4 (IQR 4.4-8.1)] and lowest in intubated ICU patients [3.6 (IQR 2.6-6.9)] (p value < 0.01). In adjusted analyses, this difference remained significant [mean difference 1.16 (95% CI 0.18-2.14)]. There was no significant difference in log10CN between other groups in the remaining pairwise comparisons. There was no association between median log10CN and mSOFA in either unadjusted or adjusted analyses or between median log10CN in patients with and without influenza immunization. There was no correlation between log10CN and D-dimer. We conclude, in our cohort, we did not find a clear association between viral load and disease severity in COVID-19 patients. Though viral load was higher in non-intubated ICU patients than in intubated ICU patients there were no other significant differences in viral load by disease severity.
引用
收藏
页码:359 / 367
页数:9
相关论文
共 50 条
  • [21] Alveolar SARS-CoV-2 Viral Load Is Tightly Correlated With Severity in COVID-19 ARDS
    Blot, Mathieu
    Jacquier, Marine
    Manoha, Catherine
    Piroth, Lionel
    Charles, Pierre-Emmanuel
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (09) : E446 - E447
  • [22] The Impact of Viral Load on the Severity and Outcome Among Patients With COVID-19: A Cross-Sectional Study
    Shire, Fatma M.
    Sharbatti, Shatha
    AlNajjar, Firas
    Suliman, Lara
    Abuelkher, Rand
    Sabri, Hebah
    Beevi, Aasiya
    Alqahtani, Alia
    Beshtawy, Rami
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [23] Nasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients
    Shlomai, Amir
    Ben-Zvi, Haim
    Glusman Bendersky, Ahinoam
    Shafran, Noa
    Goldberg, Elad
    Sklan, Ella H.
    CRITICAL CARE, 2020, 24 (01):
  • [24] Nasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients
    Amir Shlomai
    Haim Ben-Zvi
    Ahinoam Glusman Bendersky
    Noa Shafran
    Elad Goldberg
    Ella H. Sklan
    Critical Care, 24
  • [25] EFFECTS OF ATOPIC DISEASE ON DISEASE SEVERITY IN COVID-19
    Timberlake, D.
    Narayanan, D.
    Ogbogu, P.
    Raveendran, R.
    Prince, B.
    Scherzer, R.
    Porter, K.
    Grayson, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S43 - S43
  • [26] A Study on the Predictors of Disease Severity of COVID-19
    Li, Liang
    Sun, Wei
    Han, Mingfeng
    Ying, Yunli
    Wang, Quanzhi
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [27] Platelets contribute to disease severity in COVID-19
    Barrett, Tessa J.
    Bilaloglu, Seda
    Cornwell, Macintosh
    Burgess, Hannah M.
    Virginio, Vitor W.
    Drenkova, Kamelia
    Ibrahim, Homam
    Yuriditsky, Eugene
    Aphinyanaphongs, Yin
    Lifshitz, Mark
    Liang, Feng Xia
    Alejo, Julie
    Smith, Grace
    Pittaluga, Stefania
    Rapkiewicz, Amy, V
    Wang, Jun
    Iancu-Rubin, Camelia
    Mohr, Ian
    Ruggles, Kelly
    Stapleford, Kenneth A.
    Hochman, Judith
    Berger, Jeffrey S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (12) : 3139 - 3153
  • [28] ?Pneumomediastinum: A marker of severity in Covid-19 disease?
    Khaire, Nivedita
    Deshmukh, Sonali
    Agarwal, Esha
    Mahale, Nilesh
    Khaladkar, Sanjay
    Desai, Sanjay
    Kulkarni, Ashwini
    HELIYON, 2023, 9 (01)
  • [29] Anticoagulation in COVID-19: the Disease Severity depends on it
    Krome, Susanne
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (01/02) : 8 - 8
  • [30] Multivariate indicators of disease severity in COVID-19
    Bean, Joe
    Kuri-Cervantes, Leticia
    Pennella, Michael
    Betts, Michael R. R.
    Meyer, Nuala J. J.
    Hassan, Wail M. M.
    SCIENTIFIC REPORTS, 2023, 13 (01)